EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyse

Comparison of Monotherapies and Combination Therapy of Tamsulosin and Tadalafil for Treating Lower Urinary Tract Symptoms Caused by Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Meta-Analysis

Jianping Liu, Weijian Zhou, Peng Zhang, Wei Zhang, Congwang Chang, Guanghua Fu

Urologia Internationalis · 2024

DOI: 10.1159/000535606 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Urologia Internationalis, 2024. Verfasst von Jianping Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First People's Hospital of Yibin, Yibin, China, liujp0207@sina.com. Hauptthemen laut MEDLINE: Drug Therapy, Combination, Erectile Dysfunction, Lower Urinary Tract Symptoms, Prostatic Hyperplasia. Die Arbeit wurde bisher 6-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is limited research into the efficacy and safety of tadalafil combined with tamsulosin for the treatment of lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH), with or without erectile dysfunction (ED). Therefore, we aimed to investigate the efficacy and safety of combination therapy compared to that of monotherapy.

Methods

We searched PubMed, Embase, Cochrane Library, Web of Science, SinoMed, CNKI, WanFang Data Service Platform, and ClinicalTrials.gov to identify eligible studies. A total of 639 articles were retrieved, of which 12 were randomized controlled trials (RCTs) published as of February 2023 and included in this meta-analysis.

Results

After screening 639 articles, 12 RCTs including 1,531 subjects were considered eligible for the meta-analysis. The results showed that the total International Prostate System Score (total IPSS), maximum flow rate (Qmax), and quality of life (QoL) in tadalafil combined with tamsulosin were significantly better than those in monotherapy. Compared with tadalafil monotherapy, combination therapy mainly improved IPSS voiding. As for postvoid residual urine (PVR), the combination therapy did not improve PVR compared to the tadalafil group, but significantly improved PVR compared to the tamsulosin group. For the International Index of Erectile Function (IIEF), the curative effect of the combined group was better than that of the tamsulosin group but not better than that of the tadalafil group. In terms of safety, the adverse reactions (AEs) in the combined treatment group were significantly higher than those in the monotherapy group. None of the 12 RCTs reported serious adverse events.

Conclusions

Tadalafil combined with tamsulosin was more effective in the treatment of male LUTS/BPH, with or without ED, on the improvement of total IPSS, QoL, and Qmax. However, the benefits of combination therapy for ED remain unclear. However, combination therapy seemed to have a higher incidence of adverse reactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Therapy, CombinationErectile DysfunctionLower Urinary Tract SymptomsProstatic HyperplasiaTadalafilTamsulosinHumansMalePhosphodiesterase 5 InhibitorsTreatment OutcomeUrological Agents

Stichwörter der Autor:innen

Benign prostatic hyperplasiaErectile dysfunctionLower urinary tract symptomsTadalafilTamsulosin

Substanzen

Phosphodiesterase 5 InhibitorsTadalafilTamsulosinUrological Agents

Autor:innen und Institutionen

  • Department of Urology, The First People's Hospital of Yibin, Yibin, China, liujp0207@sina.com.
  • Clinical Medical Department, Weifang Medical University, Weifang, China.
  • Department of Urology, The First People's Hospital of Yibin, Yibin, China.

Zitieren

APA

Liu, J., Zhou, W., Zhang, P., Zhang, W., Chang, C., & Fu, G. (2024). Comparison of Monotherapies and Combination Therapy of Tamsulosin and Tadalafil for Treating Lower Urinary Tract Symptoms Caused by Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Meta-Analysis. Urologia Internationalis. https://doi.org/10.1159/000535606

Vancouver

Liu J, Zhou W, Zhang P, Zhang W, Chang C, Fu G. Comparison of Monotherapies and Combination Therapy of Tamsulosin and Tadalafil for Treating Lower Urinary Tract Symptoms Caused by Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Meta-Analysis. Urologia Internationalis. 2024. doi:10.1159/000535606

BibTeX
@article{Liu2024,
  author = {Liu, Jianping and Zhou, Weijian and Zhang, Peng and Zhang, Wei and Chang, Congwang and Fu, Guanghua},
  title = {Comparison of Monotherapies and Combination Therapy of Tamsulosin and Tadalafil for Treating Lower Urinary Tract Symptoms Caused by Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Meta-Analysis},
  journal = {Urologia Internationalis},
  year = {2024},
  doi = {10.1159/000535606}
}
Kostenlos starten →